rais guidanc organ outlook msd pin high end
msd fcf/ni lower due work capit solid growth/
backlog pre-buy inventori remain long-term benchmark
note end net leverag
avail liquid gross leverag compar end
share repurchas dormant sinc acquisit pipelin
activ includ larger target pipelin deal densiti time tough
handicap invest past year believ
compani could potenti execut amount period
ep beat in-lin guidanc
sale core acq fx vs estim
ep guidanc revis vs prior
y-o-i sale still low-doubl digit core mid-singl digit high
sale grew y-o-i core acq fx om
bp y-o-i bp organ vs estim emg sale
grew y-o-i core acq fx om contract bp
y-o-i vs bp estim
ep guidanc compar prior
consensu sale high-singl digit estim core record backlog
order growth organ book bill organ
order rose emg
announc acquisit motec provid integr vision
system serv high-growth mobil machin vision market annual sale
spent deal ytd note current
rais ep
rais pt target fcf-per-share given
sustain compound model highli probabl acquir prospect
solid return high fcf/ni convers strong backlog underwrit outlook
analyst certif import disclosur see disclosur
expect posit investor sentiment given
sustain compound model highli probabl
acquir prospect solid return high /ni convers
strong backlog underwrit outlook attent focus
solid order trend deal flow remain solid robust
recent deal play well oper improv capac
strong convers capit alloc prospect
acceler replenish record backlog
success mitig uncertain tariff headwind
inabl execut difficult organ comp
inabl execut integr acquisit expect
pt base /share given sustain compound model highli probabl acquir
prospect solid return high fcf/ni convers strong backlog underwrit outlook pt impli potenti upsid
includ dividend yield
risk includ weaker global growth includ us weak aerospac oil/gas/chem market inabl
complete/integr acquisit given relianc acquisit supplement top line inabl pass along higher raw materi cost
price aggress consensu ep estim time could hinder stock price perform
exhibit segment result varianc oppenheim estim
compani report oppenheim co inc estim
report ep vs year ago beat in-lin estim
guidanc revenu increas organ acquisit fx vs
estim order increas y-o-i report end record
backlog
segment oper margin expand bp y-o-i vs estim
consolid basi oper margin rose bp y-o-i core bp y-o-i edg
flow/liquid repres /ni vs full-year guid
capital-expenditure total vs full-year guid total debt off-set cash result
net debt/capit vs last year
guidanc manag rais ep guidanc vs prior y-o-
sale outlook still low-doubl digit organ sale mid-singl digit organ high
end msd msd emg hsd expect full-year tax rate
prior capital-expenditure depreci amort guid ep
vs prior consensu sale high-singl digit organ mid-singl digit
compani report oppenheim co inc estim
electron instrument revenu increas y-o-i organ acquisit
fx beat estim aerospac grew mid-teen y-o-i msd organ process increas
mid-teen hsd organ power industri grew y-o-i msd organ oper margin
expand bp y-o-i core bp y-o-i beat estim
electromechan revenu grew y-o-i organ acquisit fx
beat estim engin solut organ sale increas
oper margin contract bp y-o-i shi estim
annual sale profit segment
compani report oppenheim co inc
quarterli sale profit segment
compani report oppenheim co inc
analysi oper
segment revenu
total segment revenu
segment profit
total segment profit
compani report oppenheim co inc
year end decemb million
good sold
oper profit g/w charg
compani report oppenheim co inc
sale
oper profit g/w charg
compani report oppenheim co inc
year end decemb million
equival
intang invest asset
short-term borrow current portion ltd
average day inventori day hand
compani report oppenheim co inc
consolid statement flow
year end decemb million
inventori current asset
payabl accrual incom tax
net chang work capit
addit pp
proce sale asset discontinu op
purchas busi net cash
net chang short-term borrow
reduct long-term borrow
repurchas common stock
excess tax benefit share-bas payment
proce employe stock option
increas dec
equival -b
equival -e
compani report oppenheim co inc
